
Eric Olson
Examiner (ID: 316, Phone: (571)272-9051 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1693, 1673, 1623 |
| Total Applications | 1758 |
| Issued Applications | 971 |
| Pending Applications | 175 |
| Abandoned Applications | 632 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9099877
[patent_doc_number] => 08563754
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-10-22
[patent_title] => 'Compounds, compositions and methods for preventing skin darkening'
[patent_app_type] => utility
[patent_app_number] => 13/015882
[patent_app_country] => US
[patent_app_date] => 2011-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 20970
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13015882
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/015882 | Compounds, compositions and methods for preventing skin darkening | Jan 27, 2011 | Issued |
Array
(
[id] => 6186255
[patent_doc_number] => 20110124573
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-26
[patent_title] => 'Osmoprotective Complexes for Prevention of Intra-cellular Dehydration in Mammals'
[patent_app_type] => utility
[patent_app_number] => 13/015805
[patent_app_country] => US
[patent_app_date] => 2011-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 21718
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20110124573.pdf
[firstpage_image] =>[orig_patent_app_number] => 13015805
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/015805 | Osmoprotective complexes for prevention of intra-cellular dehydration in mammals | Jan 27, 2011 | Issued |
Array
(
[id] => 9074381
[patent_doc_number] => 08551958
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-10-08
[patent_title] => 'Galactosylated pro-drugs of non-steroidal anti-inflammatories with improved pharmacokinetic characteristics and reduced toxicity of the starting drug'
[patent_app_type] => utility
[patent_app_number] => 13/015980
[patent_app_country] => US
[patent_app_date] => 2011-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 13
[patent_no_of_words] => 6654
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13015980
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/015980 | Galactosylated pro-drugs of non-steroidal anti-inflammatories with improved pharmacokinetic characteristics and reduced toxicity of the starting drug | Jan 27, 2011 | Issued |
Array
(
[id] => 5959548
[patent_doc_number] => 20110183935
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-28
[patent_title] => 'HEARTWATER'
[patent_app_type] => utility
[patent_app_number] => 13/013477
[patent_app_country] => US
[patent_app_date] => 2011-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2946
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20110183935.pdf
[firstpage_image] =>[orig_patent_app_number] => 13013477
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/013477 | HEARTWATER | Jan 24, 2011 | Abandoned |
Array
(
[id] => 7561744
[patent_doc_number] => 20110275577
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-10
[patent_title] => 'METHODS OF TREATING DERMATOLOGIC, GYNECOLOGIC, AND GENITAL DISORDERS WITH CAFFEIC ACID ANALOGS'
[patent_app_type] => utility
[patent_app_number] => 12/987553
[patent_app_country] => US
[patent_app_date] => 2011-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16029
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20110275577.pdf
[firstpage_image] =>[orig_patent_app_number] => 12987553
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/987553 | METHODS OF TREATING DERMATOLOGIC, GYNECOLOGIC, AND GENITAL DISORDERS WITH CAFFEIC ACID ANALOGS | Jan 9, 2011 | Abandoned |
Array
(
[id] => 9239395
[patent_doc_number] => 08604187
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-12-10
[patent_title] => 'Compositions and methods of aloe polysaccharides'
[patent_app_type] => utility
[patent_app_number] => 12/985943
[patent_app_country] => US
[patent_app_date] => 2011-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 11
[patent_no_of_words] => 7130
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 260
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12985943
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/985943 | Compositions and methods of aloe polysaccharides | Jan 5, 2011 | Issued |
Array
(
[id] => 6056023
[patent_doc_number] => 20110112383
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-12
[patent_title] => 'Devices, systems and methods for treatment of eating disorders'
[patent_app_type] => utility
[patent_app_number] => 12/930377
[patent_app_country] => US
[patent_app_date] => 2011-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9603
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20110112383.pdf
[firstpage_image] =>[orig_patent_app_number] => 12930377
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/930377 | Devices, systems and methods for treatment of eating disorders | Jan 3, 2011 | Abandoned |
Array
(
[id] => 6083688
[patent_doc_number] => 20110144041
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-16
[patent_title] => 'Methods for Treating Inflammatory Bowel Disease'
[patent_app_type] => utility
[patent_app_number] => 12/966070
[patent_app_country] => US
[patent_app_date] => 2010-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 33219
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0144/20110144041.pdf
[firstpage_image] =>[orig_patent_app_number] => 12966070
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/966070 | Methods for treating inflammatory bowel disease | Dec 12, 2010 | Issued |
Array
(
[id] => 8660082
[patent_doc_number] => 20130040911
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-14
[patent_title] => 'ADHESION-PREVENTING MATERIAL'
[patent_app_type] => utility
[patent_app_number] => 13/638156
[patent_app_country] => US
[patent_app_date] => 2010-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10563
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13638156
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/638156 | ADHESION-PREVENTING MATERIAL | Dec 8, 2010 | Abandoned |
Array
(
[id] => 8612703
[patent_doc_number] => 20130018015
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-17
[patent_title] => 'Nutritional Composition and Methods of Making and Using Same'
[patent_app_type] => utility
[patent_app_number] => 13/514885
[patent_app_country] => US
[patent_app_date] => 2010-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9343
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13514885
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/514885 | Nutritional composition and methods of making and using same | Dec 7, 2010 | Issued |
Array
(
[id] => 6016444
[patent_doc_number] => 20110224130
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-15
[patent_title] => 'CROSS-LINKED GLYCOPEPTIDE-CEPHALOSPORIN ANTIBIOTICS'
[patent_app_type] => utility
[patent_app_number] => 12/962859
[patent_app_country] => US
[patent_app_date] => 2010-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 16390
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20110224130.pdf
[firstpage_image] =>[orig_patent_app_number] => 12962859
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/962859 | Cross-linked glycopeptide-cephalosporin antibiotics | Dec 7, 2010 | Issued |
Array
(
[id] => 6120921
[patent_doc_number] => 20110077217
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-31
[patent_title] => 'SELECTIVELY DEPOLYMERIZED GALACTOMANNAN POLYSACCHARIDE'
[patent_app_type] => utility
[patent_app_number] => 12/962296
[patent_app_country] => US
[patent_app_date] => 2010-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 16584
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20110077217.pdf
[firstpage_image] =>[orig_patent_app_number] => 12962296
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/962296 | SELECTIVELY DEPOLYMERIZED GALACTOMANNAN POLYSACCHARIDE | Dec 6, 2010 | Abandoned |
Array
(
[id] => 9817222
[patent_doc_number] => 08927006
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-01-06
[patent_title] => 'Methods and compositions for rapid treatment of otitis externa'
[patent_app_type] => utility
[patent_app_number] => 12/943810
[patent_app_country] => US
[patent_app_date] => 2010-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5595
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12943810
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/943810 | Methods and compositions for rapid treatment of otitis externa | Nov 9, 2010 | Issued |
Array
(
[id] => 9806355
[patent_doc_number] => 20150018301
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-15
[patent_title] => 'LRRK-2-Mediated Neuronal Toxicity'
[patent_app_type] => utility
[patent_app_number] => 13/508180
[patent_app_country] => US
[patent_app_date] => 2010-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 21400
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13508180
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/508180 | LRRK-2-Mediated Neuronal Toxicity | Nov 7, 2010 | Abandoned |
Array
(
[id] => 10062812
[patent_doc_number] => 09101640
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-08-11
[patent_title] => 'Use of Danshensu, Notoginsenoside R1 or their combination in preparation of medicaments for preventing and treating diseases caused by microcirculation disorder'
[patent_app_type] => utility
[patent_app_number] => 13/505051
[patent_app_country] => US
[patent_app_date] => 2010-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 7108
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13505051
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/505051 | Use of Danshensu, Notoginsenoside R1 or their combination in preparation of medicaments for preventing and treating diseases caused by microcirculation disorder | Nov 3, 2010 | Issued |
Array
(
[id] => 8659053
[patent_doc_number] => 20130039882
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-14
[patent_title] => 'METHOD TO MITIGATE INJURY FROM RADIATION EXPOSURE'
[patent_app_type] => utility
[patent_app_number] => 13/504585
[patent_app_country] => US
[patent_app_date] => 2010-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 2380
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13504585
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/504585 | METHOD TO MITIGATE INJURY FROM RADIATION EXPOSURE | Oct 27, 2010 | Abandoned |
Array
(
[id] => 10142171
[patent_doc_number] => 09174971
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-11-03
[patent_title] => 'Process for the preparation of compounds useful as inhibitors of SGLT2'
[patent_app_type] => utility
[patent_app_number] => 12/904233
[patent_app_country] => US
[patent_app_date] => 2010-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29539
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12904233
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/904233 | Process for the preparation of compounds useful as inhibitors of SGLT2 | Oct 13, 2010 | Issued |
Array
(
[id] => 10032652
[patent_doc_number] => 09073959
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-07-07
[patent_title] => 'Process for the production of sucrose-6-ester'
[patent_app_type] => utility
[patent_app_number] => 12/901820
[patent_app_country] => US
[patent_app_date] => 2010-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10740
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 183
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12901820
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/901820 | Process for the production of sucrose-6-ester | Oct 10, 2010 | Issued |
Array
(
[id] => 10898325
[patent_doc_number] => 08921540
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-12-30
[patent_title] => 'Low temperature, single solvent process for the production of sucrose-6-ester'
[patent_app_type] => utility
[patent_app_number] => 12/901808
[patent_app_country] => US
[patent_app_date] => 2010-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8853
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12901808
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/901808 | Low temperature, single solvent process for the production of sucrose-6-ester | Oct 10, 2010 | Issued |
Array
(
[id] => 8324428
[patent_doc_number] => 20120196824
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-02
[patent_title] => 'THERAPEUTIC AGENT FOR CEREBRAL INFARCTION'
[patent_app_type] => utility
[patent_app_number] => 13/501074
[patent_app_country] => US
[patent_app_date] => 2010-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 206638
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13501074
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/501074 | THERAPEUTIC AGENT FOR CEREBRAL INFARCTION | Oct 7, 2010 | Abandoned |